carbamazepine has been researched along with Erythromelalgia in 8 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
Erythromelalgia: A peripheral arterial disease that is characterized by the triad of ERYTHEMA, burning PAIN, and increased SKIN TEMPERATURE of the extremities (or red, painful extremities). Erythromelalgia may be classified as primary or idiopathic, familial or non-familial. Secondary erythromelalgia is associated with other diseases, the most common being MYELOPROLIFERATIVE DISORDERS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Essential erythermalgia is a rare acrosyndrome that is difficult to treat." | 5.35 | [Primary erythermalgia: efficacy of oxcarbazepine]. ( Benchikhi, H; Hmamouchi, B; Moutawakil, B; Skali Dahbi, S; Zouhair, K, 2009) |
| "Primary erythermalgia (erythromelalgia) is a rare autosomal dominant condition characterized by intermittent attacks of erythema, increased skin temperature and severe burning pain in the extremities, in a bilateral symmetrical distribution." | 5.35 | Treatment with carbamazepine and gabapentin of a patient with primary erythermalgia (erythromelalgia) identified to have a mutation in the SCN9A gene, encoding a voltage-gated sodium channel. ( Atherton, D; Elmslie, F; Mansour, S; Mortimer, P; Natkunarajah, J, 2009) |
| "Once erythromelalgia was suspected clinically, the SCN9A gene was sequenced." | 2.50 | An atypical case of SCN9A mutation presenting with global motor delay and a severe pain disorder. ( Meijer, IA; Nizard, S; Robitaille, Y; Rossignol, E; Vanasse, M, 2014) |
| "Essential erythermalgia is a rare acrosyndrome that is difficult to treat." | 1.35 | [Primary erythermalgia: efficacy of oxcarbazepine]. ( Benchikhi, H; Hmamouchi, B; Moutawakil, B; Skali Dahbi, S; Zouhair, K, 2009) |
| "Primary erythermalgia (erythromelalgia) is a rare autosomal dominant condition characterized by intermittent attacks of erythema, increased skin temperature and severe burning pain in the extremities, in a bilateral symmetrical distribution." | 1.35 | Treatment with carbamazepine and gabapentin of a patient with primary erythermalgia (erythromelalgia) identified to have a mutation in the SCN9A gene, encoding a voltage-gated sodium channel. ( Atherton, D; Elmslie, F; Mansour, S; Mortimer, P; Natkunarajah, J, 2009) |
| "Erythromelalgia is a syndrome characterized by erythema, burning pain and increased skin temperature of the affected extremities." | 1.27 | Erythromelalgia associated with acute diabetic neuropathy: an unusual condition. ( Bosch, X; Esmatjes, E; Goday, A; Gomis, R; Nubiola, A; Vendrell, J; Vilardell, E, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Patel, P | 1 |
| Zhang, Y | 1 |
| Unikel, LH | 1 |
| Edwards, C | 1 |
| Meijer, IA | 1 |
| Vanasse, M | 1 |
| Nizard, S | 1 |
| Robitaille, Y | 1 |
| Rossignol, E | 1 |
| Geha, P | 1 |
| Yang, Y | 1 |
| Estacion, M | 2 |
| Schulman, BR | 1 |
| Tokuno, H | 1 |
| Apkarian, AV | 1 |
| Dib-Hajj, SD | 2 |
| Waxman, SG | 2 |
| Skali Dahbi, S | 1 |
| Zouhair, K | 1 |
| Moutawakil, B | 1 |
| Hmamouchi, B | 1 |
| Benchikhi, H | 1 |
| Natkunarajah, J | 1 |
| Atherton, D | 1 |
| Elmslie, F | 1 |
| Mansour, S | 1 |
| Mortimer, P | 1 |
| Fischer, TZ | 1 |
| Gilmore, ES | 1 |
| Eastman, E | 1 |
| Taylor, S | 1 |
| Melanson, M | 1 |
| Theile, JW | 1 |
| Cummins, TR | 1 |
| Vendrell, J | 1 |
| Nubiola, A | 1 |
| Goday, A | 1 |
| Bosch, X | 1 |
| Esmatjes, E | 1 |
| Gomis, R | 1 |
| Vilardell, E | 1 |
1 review available for carbamazepine and Erythromelalgia
| Article | Year |
|---|---|
An atypical case of SCN9A mutation presenting with global motor delay and a severe pain disorder.
Topics: Carbamazepine; Child, Preschool; Comorbidity; Erythromelalgia; Female; Humans; Hypesthesia; Mexileti | 2014 |
7 other studies available for carbamazepine and Erythromelalgia
| Article | Year |
|---|---|
A case of sporadic erythromelalgia presenting with small fibre neuropathy.
Topics: Adult; Analgesics, Non-Narcotic; Carbamazepine; Diagnosis, Differential; Electromyography; Erythrome | 2019 |
Pharmacotherapy for Pain in a Family With Inherited Erythromelalgia Guided by Genomic Analysis and Functional Profiling.
Topics: Action Potentials; Adult; Analgesics, Non-Narcotic; Brain; Carbamazepine; Chronic Pain; DNA Mutation | 2016 |
[Primary erythermalgia: efficacy of oxcarbazepine].
Topics: Adolescent; Anticonvulsants; Antidepressive Agents; Carbamazepine; Depression; Erythromelalgia; Foot | 2009 |
Treatment with carbamazepine and gabapentin of a patient with primary erythermalgia (erythromelalgia) identified to have a mutation in the SCN9A gene, encoding a voltage-gated sodium channel.
Topics: Adolescent; Adult; Amines; Calcium Channel Blockers; Carbamazepine; Cyclohexanecarboxylic Acids; Dru | 2009 |
A novel Nav1.7 mutation producing carbamazepine-responsive erythromelalgia.
Topics: Adult; Anticonvulsants; Carbamazepine; Cell Line; Erythromelalgia; Female; Humans; Male; Mutation; N | 2009 |
Inhibition of NavĪ²4 peptide-mediated resurgent sodium currents in Nav1.7 channels by carbamazepine, riluzole, and anandamide.
Topics: Action Potentials; Arachidonic Acids; Carbamazepine; Endocannabinoids; Erythromelalgia; HEK293 Cells | 2011 |
Erythromelalgia associated with acute diabetic neuropathy: an unusual condition.
Topics: Acute Disease; Adult; Carbamazepine; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Erythromelalg | 1988 |